These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27670281)

  • 21. Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study.
    Xu Y; Shen L; Liu L; Zhang Z; Hu W
    Front Endocrinol (Lausanne); 2022; 13():843912. PubMed ID: 35898467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical differences between subtrochanteric and diaphyseal atypical femoral fractures: analyses of 51 cases at a single institution in Korean population.
    Cho YJ; Kang KC; Chun YS; Rhyu KH; Kim SJ; Jang TS
    Arch Osteoporos; 2018 May; 13(1):53. PubMed ID: 29725835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study.
    Eisenstein N; Kasavkar G; Bhavsar D; Khan FS; Paskins Z
    BMC Musculoskelet Disord; 2017 Jan; 18(1):29. PubMed ID: 28114975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.
    van de Laarschot DM; McKenna MJ; Abrahamsen B; Langdahl B; Cohen-Solal M; Guañabens N; Eastell R; Ralston SH; Zillikens MC
    J Clin Endocrinol Metab; 2020 May; 105(5):1682-99. PubMed ID: 31867670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence of and risk factors for developing atypical femoral fractures in Japan.
    Saita Y; Ishijima M; Mogami A; Kubota M; Baba T; Kaketa T; Nagao M; Sakamoto Y; Sakai K; Homma Y; Kato R; Nagura N; Miyagawa K; Wada T; Liu L; Matsuoka J; Obayashi O; Shitoto K; Nozawa M; Kajihara H; Gen H; Kaneko K
    J Bone Miner Metab; 2015 May; 33(3):311-8. PubMed ID: 24852205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphonates and atypical femoral fractures.
    Adler RA
    Curr Opin Endocrinol Diabetes Obes; 2016 Dec; 23(6):430-434. PubMed ID: 27653003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
    Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
    BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment status and radiographic features of patients with atypical femoral fractures.
    Hagino H; Endo N; Yamamoto T; Harada A; Iwamoto J; Kondo N; Mashiba T; Mori S; Nakamura J; Ohtori S; Sakai A; Takada J; Kato Y
    J Orthop Sci; 2018 Mar; 23(2):316-320. PubMed ID: 29146093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors affecting fracture location in atypical femoral fractures: A cross-sectional study with 147 patients.
    Kim JW; Kim JJ; Byun YS; Shon OJ; Oh HK; Park KC; Kim JW; Oh CW
    Injury; 2017 Jul; 48(7):1570-1574. PubMed ID: 28571705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.
    Shane E; Burr D; Ebeling PR; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster D; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Koval K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Sen HT; van der Meulen MC; Weinstein RS; Whyte M;
    J Bone Miner Res; 2010 Nov; 25(11):2267-94. PubMed ID: 20842676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur.
    Zanchetta MB; Diehl M; Buttazzoni M; Galich A; Silveira F; Bogado CE; Zanchetta JR
    J Bone Miner Res; 2014 Apr; 29(4):999-1004. PubMed ID: 24115250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication management after intramedullary nailing of atypical fractures.
    Feron JM; Cambon-Binder A
    Injury; 2017 Jun; 48 Suppl 1():S15-S17. PubMed ID: 28456365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Incidence of Atypical Femoral Fractures in Patients with Rheumatic Disease: Yamagata Prefectural Committee of Atypical Femoral Fractures (YamaCAFe) Study.
    Takakubo Y; Ohta D; Ishi M; Ito J; Oki H; Naganuma Y; Uno T; Sasaki A; Akabane T; Dairaku K; Goto S; Goto Y; Kanauchi Y; Kobayashi S; Nakajima T; Masuda K; Matsuda M; Mura N; Takenouchi K; Tsuchida H; Onuma Y; Shibuya J; Seino M; Yamaguchi O; Hiragami K; Urayama Y; Furukawa T; Okuda S; Ogura K; Nakamura T; Sasaki K; Konta T; Takagi M
    Tohoku J Exp Med; 2017 Aug; 242(4):327-334. PubMed ID: 28883214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Sydney AFF Score: A Simple Tool to Distinguish Females Presenting With Atypical Femur Fractures Versus Typical Femur Fractures.
    Crouch G; Dhanekula ND; Byth K; Burn E; Lau SL; Nairn L; Nery L; Doyle J; Graham E; Ellis A; Clifton-Bligh RJ; Girgis CM
    J Bone Miner Res; 2021 May; 36(5):910-920. PubMed ID: 33528853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress fracture of the bowed femoral shaft is another cause of atypical femoral fracture in elderly Japanese: a case series.
    Oh Y; Wakabayashi Y; Kurosa Y; Ishizuki M; Okawa A
    J Orthop Sci; 2014 Jul; 19(4):579-86. PubMed ID: 24789301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.
    Kim SY; Schneeweiss S; Katz JN; Levin R; Solomon DH
    J Bone Miner Res; 2011 May; 26(5):993-1001. PubMed ID: 21542002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy.
    Dózsai D; Ecseri T; Csonka I; Gárgyán I; Doró P; Csonka Á
    J Orthop Surg Res; 2020 Sep; 15(1):414. PubMed ID: 32933566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential bone fragility of mid-shaft atypical femoral fracture: Biomechanical analysis by a CT-based nonlinear finite element method.
    Tano A; Oh Y; Fukushima K; Kurosa Y; Wakabayashi Y; Fujita K; Yoshii T; Okawa A
    Injury; 2019 Nov; 50(11):1876-1882. PubMed ID: 31519437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic Acid.
    Kasai H; Mori Y; Ose A; Shiraki M; Tanigawara Y
    J Clin Pharmacol; 2021 May; 61(5):606-613. PubMed ID: 33135182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone Metabolism in the Healing Process of Lumbar Interbody Fusion: Temporal Changes of Bone Turnover Markers.
    Hyakkan R; Kanayama M; Takahata M; Oha F; Hashimoto T; Iwasaki N
    Spine (Phila Pa 1976); 2021 Dec; 46(23):1645-1652. PubMed ID: 33882539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.